Open Access

Selected aspects of allergy nursing

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,  and    | Jun 22, 2020

Cite

1. Sybilski AJ, Raciborski F, Lipiec A, et al. Atopic dermatitis is a serious health problem in Poland. Epidemiology studies based on the ECAP study. Postępy Dermatol Alergol. 2015;32(1):1-10.10.5114/pdia.2014.40935Search in Google Scholar

2. Odhiambo JA, Williams HC, Clayton TO, et al. ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124(6):1251-1258.10.1016/j.jaci.2009.10.009Search in Google Scholar

3. Samoliński B, Raciborski F, Lipiec A, et al. Epidemiology of allergic diseases in Poland. Pol J Allergol. 2014;1:10-8.Search in Google Scholar

4. DuBuske L. Appropriate and inappropriate use of immunotherapy. Ann Allergy Asthma Immunol 2001; 87(Suppl): 56-67.10.1016/S1081-1206(10)62196-5Search in Google Scholar

5. Joint Task Force on Practice Parameters: Allergen immunotherapy: a practice parameter. Ann. Allergy Asthma Immunol. 2003; 90:1-40.10.1016/S1081-1206(10)63600-9Search in Google Scholar

6. Jutel M, Kowalski ML, Rogala B, et al. Swoista immunoterapia alergenowa. (w) Standardy w alergologii. Cz. I. Kruszewski J, Kowalski ML (red.). Kraków: Medycyna Praktyczna, wyd. II, 2010; 152-159.Search in Google Scholar

7. Kowalski ML, Buczyłko K, Jurkiewicz D, et al. Objawy niepożądane w przebiegu immunoterapii przedsezonowej preparatem Pollinex®+Rye u pacjentów uczulonych na pyłki drzew i/lub traw – badanie wieloośrodkowe. Alergia Astma Immunol. 2001; 6(1): 45-50.Search in Google Scholar

8. Kowalski ML, Jutel M. Mechanisms of specific immunotherapy of allergic diseases. Allergy. 1998; 52: 485-492.10.1111/j.1398-9995.1998.tb04085.xSearch in Google Scholar

9. Kowalski ML. Systemic and specific treatment for a global disease: alergen immunotherapy revisited. Allergy 2006; 61(7): 791-795.10.1111/j.1398-9995.2006.01187.x16792575Search in Google Scholar

10. Kruszewski J (red.) Anafilaksja. Medycyna Praktyczna. Kraków, 2009.Search in Google Scholar

11. Fujita H, Soyka MB, Akdis CA. Mechanisms of alergen-specific immunotherapy. Clin Transl Allergy. 2012; 2(1): 2.10.1186/2045-7022-2-2339583322409879Search in Google Scholar

12. Alvarez-Cuesta E, Bousquet J, Canonica GW, et al. Standards for practical alergen-specific immunotherapy. Allergy 2006; 61 (Suppl. 82): 1-201.10.1111/j.1398-9995.2006.01219_1.x16930249Search in Google Scholar

13. Eifan AO, Shamji MH, Durham SR. Long-term clinical and immunological effects of alergen immunotherapy. Curr Opin Allergy Clin Immunol 2011; 11(6): 586-593.10.1097/ACI.0b013e32834cb99421986550Search in Google Scholar

14. Mosbech H, Osterballe O. Does the effect of immunotherapy last after termination of treatment? Allergy 1988; 43: 523.10.1111/j.1398-9995.1988.tb01631.xSearch in Google Scholar

15. Rogala B. Risk and safety of immunotherapy. Allergy 1998; 53: 474-478.10.1111/j.1398-9995.1998.tb04083.x9636805Search in Google Scholar

16. Buczyłko K, Chwała C, Wagner A, et al. Porównanie klinicznej skuteczności całorocznego przedsezonowego odczulania alergii na pyłki traw preparatem Catalet T. Alergia Astma Immunol. 2000; 5(3): 183-187.Search in Google Scholar

17. Copenhaver CC, Parker A, Patch S. Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice. Ann Allergy Asthma Immunol. 2011; 107(5): 441-445.10.1016/j.anai.2011.06.02622018617Search in Google Scholar

18. Zuberbier T, Bachert C, Bousquet PJ, et al. GA2LEN/EAACI pocketguide for alergen-specific immunotherapy for allergic rhinitic and asthma. Allergy 2010; 65: 1525-1530.10.1111/j.1398-9995.2010.02474.x21039596Search in Google Scholar

19. Światowa strategia rozpoznawania, leczenia i prewencji astmy. Raport NHLBI/WHO. Med. Prakt 2002; 6: 1-181.Search in Google Scholar

20. Passalacgua G, Duhram S. Specific Immunotherapy. J. Allergy Clin. Immunol. 2007; 119: 881-891.10.1016/j.jaci.2007.01.045Search in Google Scholar

21. Chyrek-Borowska S. Groźne dla życia objawy ogólne i narządowe w przebiegu immunoterapii swoistej i testów skórnych. [w] Stany zagrożenia życia w pneumonologii i alergologii. Płusa T (red.). Warszawa: Sanmedia, 1993; 92-98.Search in Google Scholar

22. Kruszewski J. Wstrząs anafilaktyczny. (w) Stany zagrożenia życia w pneumonologii i alergologii. Płusa T (red.). Warszawa: Sanmedia, 1993; 78-86.Search in Google Scholar

eISSN:
2450-646X
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing